Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA polymerase β subunit is a core catalytic component of the bacterial transcription machinery, encoded by the rpoB gene and characterized by a large structural domain (DPBB) that collaborates with the β′ subunit to form the active center for RNA synthesis. It participates in nucleotide incorporation, transcript elongation, and structural rearrangements during transcription. The β subunit is the direct target of rifampicin-class antibiotics, and mutations in its gene are a key mechanism of antimicrobial resistance. The β-subunit's structural and functional role is highly conserved among bacteria, and although its general function is retained in eukaryotic cells, the homologous subunit in eukaryotes is substantially different, supporting the selectivity of antibiotic targeting.
Drugs such as rifampicin bind to the β-subunit and inhibit its ability to synthesize RNA by stalling the elongation phase of transcription
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase β subunit (β (beta)).